Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
71 hedge funds and large institutions have $71.3M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 18 closing their positions.
11% less capital invested
Capital invested by funds: $79.9M → $71.3M (-$8.62M)
12% less funds holding
Funds holding: 81 → 71 (-10)
14% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 28
56% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 18
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $269K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$683K |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$624K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$468K |
| 4 |
CCMH
Cornerstone Capital Management Holdings
New York
|
+$437K |
| 5 |
Two Sigma Investments
New York
|
+$388K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.43M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.24M |
| 3 |
Millennium Management
New York
|
-$973K |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$917K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$723K |
SCMP Hedge Fund Activity: Q2 2014 in Review
71 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q2 2014, worth a combined $71.3M — down 11% from $79.9M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of SCMP and 8 opened new positions — a net loss of 10 holders — while 28 trimmed existing stakes and 24 added.
The largest buyer was Healthcare Value Capital, opening a new position worth an estimated $683K. The largest seller was TFS Capital, cutting an estimated $1.43M.
- 71 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q2 2014, down from 81 in Q1 2014.
- Funds reported $71.3M of Sucampo Pharmaceuticals, Inc. stock for Q2 2014, down 11% quarter-over-quarter.
- 8 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q2 2014 and 18 closed out, a net change of -10 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q2 2014 was Healthcare Value Capital, an estimated $683K added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q2 2014 was TFS Capital, an estimated $1.43M sold.
Based on aggregated 13F filings for Q2 2014.